Equity Research
We estimate that the effective tariff rate on EU exports into the US increases from around 10% currently to about 16% with the deal, somewhat below our previous assumption. We thus revise down our estimate of the Euro area real GDP hit from trade-related tensions to -0.4% (from -0.6% previously). As a result of the deal and the better-than-expected activity dataflow, we raise our growth forecast for 2025 Q3 by 0.1pp, for 2025 Q4 by 0.2pp, and for Q1 2026 by 0.1pp, on a rounded basis. This raises our annual average growth forecast for 2025 and 2026 by 0.1pp each to 1.1% and 1.2%, respectively.
28 Jul 2025 | Research | Economics - Sven Jari Stehn and others
USA: US and EU Announce Trade Deal, Reducing Risks Ahead of Aug. 1 Deadline
The US and EU announced the outline of a trade agreement, setting the US tariff on most EU products at 15% (including autos, pharma and semis) and eliminating EU tariffs on US products. We have already assumed a general 15% tariff rate for the EU and other US trading partners in our baseline, but the 10pp reduction in the sectoral tariffs would reduce the ultimate US effective tariff rate by 0.7pp vs. our assumptions.
28 Jul 2025 | Research | Economics - Jan Hatzius and others
Also see:
GOAL Kickstart: Goldilocks extends with further declines in trade policy uncertainty (28 Jul 2025)
Copper: Minerals Diplomacy Implies Downside Risk To S232 Tariff Pricing (28 Jul 2025)
Japan: Revising up TOPIX Target to 3,200 after US-Japan trade deal; TPX hits an all-time-high (28 Jul 2025)
Global FX Trader: Deals Don't Derail Dollar Downside (25 Jul 2025)
After consolidating for the better part of June and July, Chinese equities have recently broken out of their trading ranges, with MSCI China and CSI300 reaching their 4-year and ytd highs, respectively. Moderation of US-China trade tensions is perhaps a key contributor to the re-accelerating gains, in addition to a robust 2Q GDP print, government responses to address “involution” in key sectors, a resurgent IPO market in HK, record-breaking Southbound inflows (new 2025 GSe at US$160bn), and a wide gap between rising foreign investor interest in Chinese stocks and their still-conservative equity allocations. We retain our Overweight stance on China in a regional context, with our refreshed 12m index target pointing to 11% potential returns for MSCI China. But the 25% rally ytd (the 2nd best first seven-month returns since 2010) has further cemented our alpha over beta bias, leading us to reiterate Chinese POEs (Prominent 10) and shareholder yields thematically, and to raise Insurance and Materials (to OW) sectorally, funded by a downgrade in Banks and Real Estate.
IN THE SPOTLIGHT
While key debates have recently centered around the impact from volume based procurement (VBP) on overall healthcare (HC) spending, we highlight an increasingly important demographic — the 'silver' population (aged 50 and above) with strong 'Yuan' spending power (>Rmb3mn net worth). With this report, we introduce standalone TAM estimates for this '50+ >Rmb3mn NW' cohort, growing from Rmb221bn (US$31bn) to Rmb963bn (US$135bn) in 2024-35E, at a CAGR of 14.3%, vs. all-age/overall 50+ age population HC spending at 4.7%/5.3%, respectively.
We highlight key stocks in our coverage best positioned to benefit from the rise in high-end out-of-pocket treatments: Aier (upgrade to Buy), Eyebright (Buy), Zhifei (upgrade to Buy), Topchoice (Neutral), and Straumann (Buy).
Tianyi Yan

- Company HighlightsMicrosoft Corp. (MSFT): Deep Dive on Long-Term Growth Drivers29 Jul 2025 | 7:00am| 31pg| Research | Equity-Kash Rangan and othersHong Kong Exchanges (0388.HK): HK equity market activity pulse check; raise EPS/TP; Buy28 Jul 2025 | 1:35pm| 13pg| Research | Equity-Gurpreet Singh Sahi, CFA and othersSAP (SAPG.DE): S/4 HANA product cycle resilient with opex and working capital efficiencies offsetting headwinds; Buy29 Jul 2025 | 4:02am| 16pg| Research | Equity-Mohammed Moawalla and othersSynopsys Inc. (SNPS): Ansys brings significant synergies with the alignment of semiconductor and physical design, plus long-term financial accretion - Buy28 Jul 2025 | 4:58pm| 8pg| Research | Equity-James Schneider, Ph.D. and othersHeineken (HEIN.AS): First Take: Strong profit growth in H1 could suggest guidance is conservative; Reiterate Buy28 Jul 2025 | 2:18pm| 8pg| Research | Equity-Olivier Nicolaï and othersCadence Design Systems Inc. (CDNS): First Take: Strong quarter with guidance raised, despite impact of temporary China ban29 Jul 2025 | 4:22am| 6pg| Research | Equity-James Schneider, Ph.D. and others
- Industry HighlightsChina Transportation: Shipping and Ports: Assessing cash capability of COSCO entities regarding reported participation in acquisition of ports29 Jul 2025 | 8:02am| 11pg| Research | Equity-Herbert Lu and othersChina Property Weekly Wrap: Week 30 Wrap - Primary transactions rebounded while secondary held steady29 Jul 2025 | 8:10am| 16pg| Research | Equity-Yi Wang, CFA and othersAmericas Aerospace & Defense: DOGE update shows incremental revisions at DoD; reiterate cautious Gov't IT & Services view29 Jul 2025 | 2:40am| 7pg| Research | Equity-Noah Poponak, CFA and othersHealthcare: Pharmaceuticals: Update on Section 232 remains key post EU trade deal29 Jul 2025 | 2:29am| 7pg| Research | Equity-Matt Dellatorre, Ph.D. and othersEurope Multi-Industry: China Import/Export Tracker: China Trade Tracker and what it foretells for European Capital Goods — June 202526 Jul 2025 | 1:42am| 53pg| Research | Equity-Daniela Costa and othersUS Autos & Industrial Tech: 5 days in 5 minutes28 Jul 2025 | 6:29pm| 8pg| Research | Equity-Mark Delaney, CFA and others
- PORTFOLIO STRATEGYGlobal Weekly Kickstart: Global markets up, Japan leads after trade deal28 Jul 2025 | 9:56pm| 21pg| Research | Portfolio Strategy-Guillaume Jaisson and othersUS Macroscope: Speculative trading activity adds fuel to narrow-breadth short squeeze25 Jul 2025 | 5:09am| 11pg| Research | Portfolio Strategy-Ben Snider and othersUS Thematic Views: The resurgence of the S&P 500 index inclusion effect24 Jul 2025 | 4:00am| 12pg| Research | Portfolio Strategy-Ryan Hammond and others
- OPTIONSOptimal Overwrites this week (28-Jul-25)28 Jul 2025 | 9:17pm| 17pg| Research | Options-Rohith Medarametla and othersWeekend Cross-asset Dislocations (27-Jul-2025)27 Jul 2025 | 7:38pm| 1pg| Research | Options-John MarshallTactical Hedging Update (25-July-2025)25 Jul 2025 | 8:44pm| 1pg| Research | Options-Arun Prakash, CFA
- All
- Upgrades
- Downgrades
- Initiations
- CL Adds
- CL Removes
Rating changes (last 24 hrs)
EPS changes (10% or more, last 24 hrs)
Price target changes (10% or more, last 24 hrs)
European AI and Semis Symposium
30-31 Jul 2025 | London | Virtual
Register | Agenda
Asia Leaders Conference
3-5 Sep 2025 | Hong Kong with virtual access
Register
European Medtech & Healthcare Services Conference
3-4 Sep 2025 | London
Register | Agenda
32nd Annual Global Retailing Conference
3-4 Sep 2025 | New York
Register
Communacopia + Technology Conference
8-11 Sep 2025 | San Francisco
Register
European Communacopia Conference
16-17 Sep 2025 | London
Register
14th German Corporate Conference
22-24 Sep 2025 | Munich
Register




